Healthcare IT Today September 26, 2024
Healthcare IT News

Sonio, the MedTech company specializing in women’s and children’s health, today announces the official approval by the French Ministry of the Economy and Finance of the acquisition of 100% of shares by Samsung.

The deal closes following the company’s second wave of FDA clearance in 2024 and with Sonio reporting and workflow solutions operating in multiple sites across the US.

“Alongside Samsung Medison, we are excited to make significant strides in the maternal care industry. In addition, Sonio plans to continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare” says Cécile Brosset, Co-Founder and CEO at Sonio.

Established in 2020 to enhance women’s and children’s health globally through medical advancements, and supported by...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
Related Articles:
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article